Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.

Kim SM, Kwon CH, Shin N, Park DY, Moon HJ, Kim GH, Jeon TY.

Int J Cancer. 2014 Jan 1;134(1):114-24. doi: 10.1002/ijc.28345. Epub 2013 Jul 16.

2.

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.

Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY, Jo HJ, Kim DH, Kim GH, Park DY.

Br J Cancer. 2014 Nov 11;111(10):1993-2002. doi: 10.1038/bjc.2014.490. Epub 2014 Sep 11.

3.

Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.

Kang H, An HJ, Song JY, Kim TH, Heo JH, Ahn DH, Kim G.

Histopathology. 2012 Oct;61(4):576-86. doi: 10.1111/j.1365-2559.2012.04274.x.

PMID:
22691042
4.

Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.

Guo J, Zu G, Zhou T, Xing J, Wang Z.

Clin Transl Oncol. 2015 Oct;17(10):788-94. doi: 10.1007/s12094-015-1305-z. Epub 2015 May 29.

PMID:
26022133
5.

KITENIN is associated with tumor progression in human gastric cancer.

Ryu HS, Park YL, Park SJ, Lee JH, Cho SB, Lee WS, Chung IJ, Kim KK, Lee KH, Kweon SS, Joo YE.

Anticancer Res. 2010 Sep;30(9):3479-86.

PMID:
20944126
6.

Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.

Shin NR, Jeong EH, Choi CI, Moon HJ, Kwon CH, Chu IS, Kim GH, Jeon TY, Kim DH, Lee JH, Park DY.

BMC Cancer. 2012 Nov 14;12:521. doi: 10.1186/1471-2407-12-521.

7.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.

PMID:
23334926
8.

An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.

Sun GG, Sheng SH, Jing SW, Hu WN.

Tumour Biol. 2014 Mar;35(3):2641-8. doi: 10.1007/s13277-013-1347-1. Epub 2013 Nov 16.

PMID:
24241900
9.

Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.

Tang C, Gao X, Liu H, Jiang T, Zhai X.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):4782-94. eCollection 2014.

10.

Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.

Ru GQ, Wang HJ, Xu WJ, Zhao ZS.

Pathol Oncol Res. 2011 Jun;17(2):341-7. doi: 10.1007/s12253-010-9332-0. Epub 2010 Nov 23.

PMID:
21104359
11.

Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.

Min L, Ruan Y, Shen Z, Jia D, Wang X, Zhao J, Sun Y, Gu J.

Histopathology. 2015 Nov;67(5):677-88. doi: 10.1111/his.12695. Epub 2015 May 19.

PMID:
25809930
12.

Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.

Xu XY, Gou WF, Yang X, Wang GL, Takahashi H, Yu M, Mao XY, Takano Y, Zheng HC.

Tumour Biol. 2012 Dec;33(6):1845-54. doi: 10.1007/s13277-012-0444-x. Epub 2012 Sep 5.

PMID:
22948776
13.

Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.

Wang Z, He YL, Cai SR, Zhan WH, Li ZR, Zhu BH, Chen CQ, Ma JP, Chen ZX, Li W, Zhang LJ.

Int J Cancer. 2008 Sep 15;123(6):1439-47. doi: 10.1002/ijc.23643.

14.

Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.

Yu W, Ma S, Wang L, Zuo B, Li M, Qiao Z, Pan X, Liu Y, Wang J.

Histol Histopathol. 2013 Dec;28(12):1629-38. doi: 10.14670/HH-28.1629. Epub 2013 Jul 9.

PMID:
23836308
15.

CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.

Li C, Liu DR, Li GG, Wang HH, Li XW, Zhang W, Wu YL, Chen L.

World J Gastroenterol. 2015 May 28;21(20):6215-28. doi: 10.3748/wjg.v21.i20.6215.

16.

Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.

Ito T, Yamada S, Tanaka C, Ito S, Murai T, Kobayashi D, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Kodera Y.

Ann Surg Oncol. 2014 Feb;21(2):560-8. doi: 10.1245/s10434-013-3246-5. Epub 2013 Sep 18.

PMID:
24046108
17.

Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.

Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, Hsieh FJ, Lee PH, Kuo ML, Lee H, Chang KJ.

Ann Surg Oncol. 2009 Feb;16(2):524-33. doi: 10.1245/s10434-008-0243-1. Epub 2008 Dec 3.

PMID:
19050968
18.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

19.

Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients.

Zheng Y, Wang DD, Wang W, Pan K, Huang CY, Li YF, Wang QJ, Yuan SQ, Jiang SS, Qiu HB, Chen YM, Zhang XF, Zhao BW, Mai C, Xia JC, Zhou ZW.

PLoS One. 2014 Apr 3;9(4):e93073. doi: 10.1371/journal.pone.0093073. eCollection 2014.

20.

Prognostic value of Muc5AC in gastric cancer: A meta-analysis.

Zhang CT, He KC, Pan F, Li Y, Wu J.

World J Gastroenterol. 2015 Sep 28;21(36):10453-60. doi: 10.3748/wjg.v21.i36.10453. Review.

Supplemental Content

Support Center